Meet Team Norway at ESRR 2026

Team Norway attended ESRR in Bergen, 16–19 April 2026, at booths 20 and 21 to represent Norway’s radiopharmaceutical sector. Invest in Norway and NorTrials presented Norway’s capacity across radiochemistry/nuclear medicine research, isotope production, radiopharmaceutical development, CDMO services, clinical translation, and commercialization. The page also cites public–private collaboration, predictable regulation/market access, and access to European/global markets. Partners: NorTrials and Invest in Norway. Contact: Signe Øien Fretland, Head of NorTrials coordinating unit (sigfre@ous-hf.no); page contact: Maria Aulie (maria.aulie@innovasjonnorge.no). Linked content covers radiopharma and Norwegian precision-medicine/cancer research.